Jane Street’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Sell |
28,860
-185,566
| -87% | -$3.78M | ﹤0.01% | 3510 |
|
|
2025
Q1 | $3.89M | Buy |
214,426
+128,844
| +151% | +$2.34M | ﹤0.01% | 1590 |
|
|
2024
Q4 | $2.16M | Sell |
85,582
-88,088
| -51% | -$2.23M | ﹤0.01% | 2014 |
|
|
2024
Q3 | $5.9M | Sell |
173,670
-16,659
| -9% | -$566K | ﹤0.01% | 1160 |
|
|
2024
Q2 | $7.04M | Buy |
190,329
+13,448
| +8% | +$498K | ﹤0.01% | 1362 |
|
|
2024
Q1 | $7.42M | Buy |
176,881
+48,720
| +38% | +$2.04M | ﹤0.01% | 996 |
|
|
2023
Q4 | $5.08M | Buy |
128,161
+68,747
| +116% | +$2.73M | ﹤0.01% | 1492 |
|
|
2023
Q3 | $1.64M | Buy |
59,414
+34,457
| +138% | +$948K | ﹤0.01% | 2435 |
|
|
2023
Q2 | $847K | Sell |
24,957
-42,902
| -63% | -$1.46M | ﹤0.01% | 3233 |
|
|
2023
Q1 | $2.44M | Buy |
67,859
+24,650
| +57% | +$887K | ﹤0.01% | 1818 |
|
|
2022
Q4 | $1.93M | Buy |
43,209
+9,899
| +30% | +$441K | ﹤0.01% | 2034 |
|
|
2022
Q3 | $937K | Sell |
33,310
-142,196
| -81% | -$4M | ﹤0.01% | 2855 |
|
|
2022
Q2 | $4.73M | Buy |
175,506
+97,097
| +124% | +$2.62M | ﹤0.01% | 1141 |
|
|
2022
Q1 | $2.67M | Buy |
78,409
+56,209
| +253% | +$1.91M | ﹤0.01% | 1831 |
|
|
2021
Q4 | $858K | Buy |
22,200
+9,952
| +81% | +$385K | ﹤0.01% | 2894 |
|
|
2021
Q3 | $661K | Sell |
12,248
-43,688
| -78% | -$2.36M | ﹤0.01% | 3130 |
|
|
2021
Q2 | $1.87M | Buy |
55,936
+36,572
| +189% | +$1.22M | ﹤0.01% | 1828 |
|
|
2021
Q1 | $399K | Sell |
19,364
-14,768
| -43% | -$304K | ﹤0.01% | 3606 |
|
|
2020
Q4 | $598K | Buy |
+34,132
| New | +$598K | ﹤0.01% | 2584 |
|
|
2020
Q3 | – | Sell |
-13,876
| Closed | -$180K | – | 3806 |
|
|
2020
Q2 | $180K | Buy |
+13,876
| New | +$180K | ﹤0.01% | 3451 |
|
|
2018
Q3 | – | Sell |
-11,808
| Closed | -$89K | – | 3503 |
|
|
2018
Q2 | $89K | Buy |
+11,808
| New | +$89K | ﹤0.01% | 3072 |
|
|
2018
Q1 | – | Sell |
-1,257
| Closed | -$54K | – | 3127 |
|
|
2017
Q4 | $54K | Buy |
1,257
+501
| +66% | +$21.5K | ﹤0.01% | 2944 |
|
|
2017
Q3 | $32K | Buy |
+756
| New | +$32K | ﹤0.01% | 2792 |
|
|
2016
Q4 | – | Sell |
-715
| Closed | -$43K | – | 2607 |
|
|
2016
Q3 | $43K | Buy |
+715
| New | +$43K | ﹤0.01% | 2653 |
|
|
2016
Q2 | – | Sell |
-2,677
| Closed | -$152K | – | 2624 |
|
|
2016
Q1 | $152K | Sell |
2,677
-2,384
| -47% | -$135K | ﹤0.01% | 2355 |
|
|
2015
Q4 | $1.19M | Buy |
+5,061
| New | +$1.19M | 0.01% | 935 |
|
|
2015
Q3 | – | Sell |
-646
| Closed | -$244K | – | 2512 |
|
|
2015
Q2 | $244K | Sell |
646
-1,337
| -67% | -$505K | ﹤0.01% | 2064 |
|
|
2015
Q1 | $829K | Buy |
1,983
+1,285
| +184% | +$537K | 0.01% | 1050 |
|
|
2014
Q4 | $191K | Buy |
+698
| New | +$191K | ﹤0.01% | 1610 |
|
|
2013
Q4 | – | Sell |
-4,693
| Closed | -$2.49M | – | 2119 |
|
|
2013
Q3 | $2.49M | Buy |
4,693
+87
| +2% | +$46.2K | 0.03% | 337 |
|
|
2013
Q2 | $1.08M | Buy |
+4,606
| New | +$1.08M | 0.02% | 674 |
|